Crossmark

Immune checkpoint inhibitor-related diabetes mellitus associated with high signal intensity in diffusion-weighted magnetic resonance imaging of the pancreas at an early clinical stage

Crossref DOI link: https://doi.org/10.1007/s42000-025-00629-3

Published Online: 2025-01-17

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Masaki https://orcid.org/0000-0002-0677-7828
Hirota, Yushi https://orcid.org/0000-0002-3035-4155
Urai, Shin https://orcid.org/0000-0002-7996-232X
Yamamoto, Masaaki https://orcid.org/0000-0002-7000-8134
Sofue, Keitaro https://orcid.org/0000-0001-6132-1623
Ogawa, Wataru https://orcid.org/0000-0002-0432-4366
Funding

Funding for this research was provided by:

Kobe University
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 27 July 2024

Accepted: 8 January 2025

First Online: 17 January 2025

Declarations

:

: Not applicable

: The patient provided written informed consent expressly permitting journal submission.

: None declared

Document is current

Any future updates will be listed below